DNA/lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 3, 2007, Pages 603-607

  Hattori, Yoshiyuki ^a   Maitani, Yoshie ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Collagen I; Fibronectin; Nanoparticle; Prostate tumor; Transfection

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; HERMES ANTIGEN; LAMININ; MESSENGER RNA; NANOPARTICLE; PLASMID DNA; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL ADHESION; COMPLEX FORMATION; CONTROLLED STUDY; DNA MICROARRAY; DNA TRANSFECTION; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENE TRANSFER; HUMAN; HUMAN CELL; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; ANTIGENS, CD44; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COLLAGEN TYPE I; DNA; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA2BETA1; LAMININ; LIPIDS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; PARTICLE SIZE; PROSTATIC NEOPLASMS; RNA, MESSENGER; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33847671410     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.603     Document Type: Article

References (23)

1. Scott G., Cassidy L., Busacco, A., J. Invest Dermatol., 108, 147-153 (1997).
2. Saiki I., Jpn. J. Pharmacol., 75, 215-242 (1997).
3. Romanov V. I., Goligorsky M. S., Prostate, 39, 108-118 (1999).
4. Anwer K., Kao G., Rolland A., Driessen W. H., Sullivan S. M., J. Drug Target, 12, 215-221 (2004).
5. Harvie P., Dutzar B., Galbraith T., Cudmore S., O'Mahony D., Anklesaria P., Paul R., J. Liposome Res., 13, 231-247 (2003).
6. Schiffelers R. M., Ansari A., Xu J., Zhou Q., Tang Q., Storm G., Molema G., Lu P. Y., Scaria P. V., Woodle M. C., Nucleic Acids Res., 32, e149 (2004).
7. Kunath K., Merdan T., Hegener O., Haberlein H., Kissel T., J. Gene Med., 5, 588-599 (2003).
8. Jenkins R. G., Meng Q. H., Hodges R. J., Lee L. K., Bottoms S. E., Laurent G. J., Willis D., Ayazi S. P., McAnulty R. J., Hart S. L., Gene Ther., 10, 1026-1034 (2003).
9. Hart S. L., Arancibia-Carcamo C. V., Wolfert M. A., Mailhos C., O'Reilly N. J., Ali R. R., Coutelle C., George A. J., Harbottle R. P., Knight A. M., Larkin D. F., Levinsky R. J., Seymour L. W., Thrasher A. J., Kinnon C., Hum. Gene Ther., 9, 575-585 (1998).
10. Chowdhury E. H., Nagaoka M., Ogiwara K., Zohra F. T., Kutsuzawa K., Tada S., Kitamura C., Akaike T., Biochemistry, 44, 12273-12278 (2005).
11. Hattori Y., Kubo H., Higashiyama K., Maitani Y., J. Biomed. Nanotech., 1, 176-184 (2005).
12. Igarashi S., Hattori Y., Maitani Y., J. Control Release, 112, 362-368 (2006).
13. Hattori Y., Maitani Y., Cancer Gene Ther., 12, 796-809 (2005).
14. Hattori Y., Maitani Y., Cancer Sci., 97, 787-798 (2006).
15. Aalinkeel R., Nair M. P., Sufrin G., Mahajan S. D., Chadha K. C., Chawda R. P., Schwartz S. A., Cancer Res., 64, 5311-5321 (2004).
16. Dhir R., Gau J. T., Krill D., Bastacky S., Bahnson R. R., Cooper D. L., Becich M. J., Mol. Diagn., 2, 197-204 (1997).
17. Kostenuik P. J., Sanchez-Sweatman O., Orr F. W., Singh G., Clin. Exp. Metastasis, 14, 19-26 (1996).
18. Almofti M. R., Harashima H., Shinohara Y., Almofti A., Li W., Kiwada H., Mol. Membr. Biol., 20, 35-43 (2003).
19. Escriou V., Ciolina C., Lacroix F., Byk G., Scherman D., Wils P., Biochim. Biophys. Acta, 1368, 276-288 (1998).
20. Turek J., Dubertret C., Jaslin G., Antonakis K., Scherman D., Pitard B., J. Gene Med., 2, 32-40 (2000).
21. Halter M., Antia M., Vogel V., J. Control Release, 101, 209-222 (2005).
22. Goodison S., Urquidi V., Tarin D., Mol. Pathol., 52, 189-196 (1999).
23. Fornaro M., Manes T., Languino L. R., Cancer Metastasis Rev., 20, 321-331 (2001).